Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanodox Hydrogel in Atopic Dermatitis
NCT02910011Phase 2Completed
- Sponsor
- University of Florida
- Start
- May 2017
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of doxycycline in atopic dermatitis (AD), sponsored by University of Florida. Primary endpoint: Number of Participants With Treatment-related Adverse Events as Assessed by CTCAE v4.0 up to 4 weeks. Started May 2017; status: completed.
02
Drugs
doxycycline
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02910011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02910011.